Can analytical methods for combining randomized with non-randomized evidence address issues around uncertainty and build trust when estimating treatment effects for new technologies? The panel will debate this and explore the potential of using these novel analytical methods in HTA. It will also propose a newly developed framework for their integration in decision-making and explore acceptance of its use.